Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2020
Reporting Period: Single event date (January 13, 2020)
Business Context: The registrant is an emerging growth company incorporated in Delaware, with principal executive offices in South San Francisco, California. Its common stock trades on The Nasdaq Global Select Market under the symbol "IDYA".
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document serves solely to disclose the release of a corporate presentation.
Material Changes
Regulation FD Disclosure: On January 13, 2020, the Company began using a new corporate presentation ("Corporate Presentation") and made it available on its website. This presentation is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The filing explicitly states that the information contained in Item 7.01 and the attached Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. Consequently, this information is not subject to the liabilities of that section and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed within the text of this 8-K filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Corporate Presentation) for specific strategic updates or data not included in this summary.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm that the Corporate Presentation is available on the Company's official website as of January 13, 2020.
- Note that the content of the Corporate Presentation is not legally "filed" with the SEC and carries different liability standards than formal financial reports.